Skip to main content

Anagrelide Hydrochloride

Type of Posting: Revision Bulletin

Posting Date: 31–May–2013

Official Date: 01–Jun–2013

Archive Date: 09–Feb–2015

Expert Committee: Monographs—Small Molecules 2

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Anagrelide Hydrochloride monograph. The purpose of this revision is to include a process specific impurity, anagrelide open ring methyl ester, with acceptance criteria of NMT 0.25%, to be consistent with the sponsor's FDA-approved specifications. The limit for total impurities remains unchanged.

The Anagrelide Hydrochloride Revision Bulletin supersedes the currently official monograph. This Revision Bulletin will be incorporated in the USP 37–NF 32.

Should you have any questions, please contact Sujatha Ramakrishna Ph.D., M.B.A. (301-816-8349 or sxr@usp.org).